Evaluation of Bioactive Giomer Material Versus Nanohybrid Resin Composite in Deep Marginal Elevation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-50
SponsorCairo University
About this trial
This study will be conducted to evaluate the clinical, radiographic and periodontal performance of bioactive Giomer compared to nanohybrid resin composite restoration in deep subgingival proximal cavities extending below the CEJ over a period of 24 months.
Eligibility criteria
Qualifiers
Young and middle aged patients (20-50)
Good or moderate oral hygiene (plaque index 0 or 1 )
Patient approval
Absence of parafunctional habits and/or bruxism
Disqualifiers
Patients with known allergic or adverse reaction to the tested materials.
Systematic disease that may affect participation.
Xerostomic patients.
Patients with active periodontal disease.
Trial design
Treatments tested in this trial
- Beautifil II LS
- Nanohybrid resin composite material
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov